Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.430
+0.090 (6.72%)
Mar 11, 2025, 4:00 PM EST - Market closed
Neumora Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '25 Mar 11, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 232 | 1,713 | 2,604 | - | - | - | |
| Market Cap Growth | -34.22% | -34.22% | - | - | - | - | |
| Enterprise Value | -74 | 1,374 | 2,090 | - | - | - | |
| Last Close Price | 1.43 | 10.60 | 17.05 | - | - | - | |
| PB Ratio | 0.81 | 5.97 | 5.55 | - | - | - | |
| P/TBV Ratio | 5.97 | 5.97 | 5.55 | - | - | - | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | |
| Quick Ratio | 10.29 | 10.29 | 18.08 | 15.73 | 17.59 | 20.50 | |
| Current Ratio | 10.51 | 10.51 | 19.05 | 16.37 | 17.85 | 20.69 | |
| Return on Equity (ROE) | -64.48% | -64.48% | -54.49% | -32.67% | -80.18% | -106.02% | |
| Return on Assets (ROA) | -40.50% | -40.50% | -25.50% | -17.95% | -16.01% | - | |
| Return on Capital (ROIC) | -43.15% | -43.15% | -26.74% | -18.92% | -16.85% | -16.97% | |
| Earnings Yield | -105.25% | -14.24% | -9.06% | - | - | - | |
| FCF Yield | -78.98% | -10.68% | -6.28% | - | - | - | |
| Buyback Yield / Dilution | -145.12% | -145.12% | -138.99% | -24.25% | -68.46% | - | |
| Total Shareholder Return | -145.12% | -145.12% | -138.99% | -24.25% | -68.46% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.